Macrogenics Inc (NAS:MGNX)
$ 4.36 0.25 (6.07%) Market Cap: 273.08 Mil Enterprise Value: 107.83 Mil PE Ratio: 0 PB Ratio: 2.57 GF Score: 60/100

MacroGenics Inc at JMP Securities Life Sciences Conference Transcript

Jun 16, 2022 / 04:00PM GMT
Release Date Price: $2.25 (-4.26%)
Silvan Tuerkcan
JMP Securities LLC - Analyst

Thanks. Welcome back. It's my pleasure to host Scott Koenig, CEO of MacroGenics. Thanks for joining us today.

Scott Koenig
MacroGenics, Inc. - President, CEO, & Director

Oh, Silvan, it's a real pleasure. Thank you for the invitation.

Questions & Answers

Silvan Tuerkcan
JMP Securities LLC - Analyst

Yeah, thanks. So maybe I want to start off, just to remind the investors -- they're not as familiar with the story. You have a very broad pipeline. Could you just tell us -- and you have an approved medicine. So maybe you could just briefly tell us about -- quickly -- your pipeline and also what the unique capabilities are of the company in regards to antibody design.

Scott Koenig
MacroGenics, Inc. - President, CEO, & Director

My pleasure. So MacroGenics is a company that's been in existence since 2000 -- over 20 years of operation. We built this company from the ground up as a -- focused on immune-based

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot